Myriad wins gene patent ruling from US appeals court
(Reuters) - A U.S. federal appeals court has once again affirmed the right of Myriad Genetics Inc to patent two genes linked to breast and ovarian cancer, after the U.S. Supreme Court told it to take another look at the hotly contested case.
Sent from my iPhone
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.